Articles From: Valmont Industries, Inc. Fourth Quarter 2012 Earnings Conference Call to Vanda Pharmaceuticals Reports First Quarter 2013 Results


2013/2/6
OMAHA, Neb.
Sign-up for Valmont Industries, Inc. Fourth Quarter 2012 Earnings Conference Call investment picks
2013/4/30
OMAHA, Neb.
Sign-up for Valmont Raises Dividend by 11.1% investment picks
2013/4/29
The Valspar Corporation (NYSE:VAL) today announced that its second quarter earnings for fiscal 2013 will be broadcast live via the Internet on Tuesday, May 14, 2013, at 10:00 a.m. CT.
Sign-up for Valspar Announces Fiscal 2013 Second Quarter Earnings Conference Call investment picks
2013/3/4
The Valspar Corporation (NYSE: VAL) announced today that James L.
Sign-up for Valspar Announces New Chief Financial and Administrative Officer investment picks
2013/2/21
The Valspar Corporation (NYSE: VAL) today announced that its Board of Directors declared a quarterly dividend of $0.23 per share on the company’s common stock.
Sign-up for Valspar Declares Quarterly Dividend investment picks
2013/4/4
The Valspar Corporation (NYSE: VAL) today announced an expanded retail paint program, now available at Lowe’s, specifically tailored to the needs of the professional painter.
Sign-up for Valspar Expands Pro Paint Program with Lowe’s to Serve Unique Needs of Professional Painters investment picks
2013/2/12
The Valspar Corporation (NYSE: VAL) today reported its results for the first-quarter ended January 25, 2013.
Sign-up for Valspar Reports Fiscal 2013 First-Quarter Results investment picks
2013/5/14
The Valspar Corporation (NYSE: VAL) today reported second quarter 2013 net sales of $1.03 billion, equal to the prior year.
Sign-up for Valspar Reports Fiscal 2013 Second-Quarter Results investment picks
2013/3/4
NEW YORK , March 4, 2013 /PRNewswire/ -- Value Line Funds, a $2 billion mutual fund company serving investors since 1950, has announced that two of its mutual funds have undergone a name change to better reflect their investment objectives and strategies.
Sign-up for Value Line Funds Renames Two Funds investment picks
2013/2/12
Value Line, Inc., (NASDAQ: VALU ) announced today that on February 7, 2013, Value Line, Inc. (“Value Line” or “Company”) and Citibank, N.A. (the “Sublandlord”) entered into a sublease agreement, pursuant to which Value Line will lease approximately 44,493 square feet of office space located on the ninth floor at 485 Lexington Ave., New York, NY (“Building” or “Premises”) in the heart of the nation’s financial capital, beginning on or about July 1, 2013 and ending on February 27, 2017.
Sign-up for Value Line, Inc. Announces a New Sublease Agreement for Relocation of Corporate Offices investment picks
2013/4/18
Value Line, Inc., (NASDAQ: VALU ) announced today that its Board of Directors declared on April 18, 2013 a quarterly cash dividend of $0.15 per share of common stock, payable on May 9, 2013, to stockholders of record on April 30, 2013.
Sign-up for Value Line, Inc. Announces a Quarterly Cash Dividend of $0.15 Per Common Share investment picks
2013/3/13
Value Line, Inc., (NASDAQ: VALU ) reported results for the third fiscal quarter ended January 31, 2013.
Sign-up for Value Line, Inc. Announces Third Quarter Earnings investment picks
2013/5/3
The value of the planned deal by IntercontinentalExchange Inc. (ICE) to buy NYSE Euronext (NYX) passed $10 billion Friday as both stocks hit 52-week highs.
Sign-up for Value of Proposed ICE Deal to Buy NYSE Euronext Surpasses $10 Billion investment picks
2013/5/3
The value of the planned deal by IntercontinentalExchange Inc. (ICE) to buy NYSE Euronext (NYX) passed $10 billion Friday as both stocks hit 52-week highs.
Sign-up for Value of Proposed ICE Deal to Buy NYSE Tops $10 Billion investment picks
2013/2/4
Briefing by The Advisory Board Company provides front-line view and CMS official's perspective on what is -- and is not --
Sign-up for Value-Based Payment Incentives Heighten Hospitals' Focus on Quality, Efficiency, and Readmissions investment picks
2013/2/5
PARSIPPANY, N.J., Feb.
Sign-up for Value-Conscious Travelers Can 'Go Budget' in Model-Year 2013 Vehicles investment picks
2013/4/22
Activist hedge fund Valueact will announce Monday that it has taken a $2 billion stake in Microsoft Corp.
Sign-up for Valueact Taking $2 Billion Stake in Microsoft -CNBC investment picks
2013/5/7
ValueClick, Inc. (NASDAQ: VCLK) today reported financial results for the first quarter ended March 31, 2013.
Sign-up for ValueClick Announces First Quarter 2013 Results investment picks
2013/3/14
ValueClick, Inc. (NASDAQ: VCLK) today announced that Mr.
Sign-up for ValueClick Appoints Chief Marketing Officer investment picks
2013/4/17
ValueClick, Inc. (NASDAQ: VCLK) today announced it will release its first quarter 2013 financial results on Tuesday, May 7, after the close of the market.
Sign-up for ValueClick to Announce First Quarter 2013 Financial Results on May 7 investment picks
2013/5/7
http://media.marketwire.com/attachments/201006/609886_2009_ShopNBC_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1014272&ProfileId=051205&sourceType=1 MINNEAPOLIS, MN --
Sign-up for ValueVision Expands PNC Bank Credit Facility to $50 Million and Extends Term investment picks
2013/3/6
http://media.marketwire.com/attachments/201006/609886_2009_ShopNBC_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=993817&ProfileId=051205&sourceType=1 MINNEAPOLIS, MN --
Sign-up for ValueVision Media Reports Q4 and Fiscal 2012 Results investment picks
2013/2/20
http://media.marketwire.com/attachments/201006/609886_2009_ShopNBC_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=987596&ProfileId=051205&sourceType=1 MINNEAPOLIS, MN --
Sign-up for ValueVision Media to Report Q4 FY 2012 Results and Host Conference Call March 6 at 4:30 p.m. ET investment picks
2013/2/27
http://media.marketwire.com/attachments/201006/609886_2009_ShopNBC_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=990314&ProfileId=051205&sourceType=1 MINNEAPOLIS, MN --
Sign-up for ValueVision to Present at Piper Jaffray Technology, Media and Telecommunications Conference in New York City on March 13 investment picks
2013/4/2
American Express, in partnership with VEVO and YouTube, announced today that Vampire Weekend, and award-winning actor, director and producer Steve Buscemi, have been selected to kick-off the fourth year in its popular live stream music series, “American Express Unstaged.” Vampire Weekend’s exclusive performance will be live streamed on the last night of the Tribeca Film Festival at Roseland Ballroom on Sunday, April 28 th at 9 PM ET / 6 PM PT in New York City at www.amexunstaged.com .
Sign-up for Vampire Weekend and Emmy® Nominated Director Steve Buscemi Named as First Pairing in “American Express® Unstaged” for 2013 investment picks
2013/3/1
Assets under management in Van Eck’s recently introduced Unconstrained Emerging Markets Bond Fund (Advisor – EMBAX; Institutional - EMBUX) reached $100 million just six months after launch and now stand at $130 million.
Sign-up for Van Eck Unconstrained Emerging Markets Bond Fund Passes $100 Million AUM Mark in Six Months investment picks
2013/3/11
Vancive Medical Technologies™ will showcase new digital healthcare solutions and discuss future technology developments, as well as exhibit a range of innovative solutions for commercial partners, developers and manufacturers at the Healthcare Innovation Expo, March 13 – 14, 2013, ExCel London, Booth CC12.
Sign-up for Vancive Medical Technologies™ Exhibits Digital Healthcare Solutions and Other Products That Inspire Innovation at Healthcare Innovation Expo investment picks
2013/1/31
WASHINGTON , Jan.
Sign-up for Vanda Announces Phase IIb/III Clinical Study In Major Depressive Disorder Did Not Meet The Primary Endpoint investment picks
2013/4/17
WASHINGTON , April 17, 2013 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) , announced today that it has named Paolo Baroldi , M.D., Ph.D. as its Senior Vice President and Chief Medical Officer.
Sign-up for Vanda Pharmaceuticals Appoints Dr. Paolo Baroldi As Chief Medical Officer investment picks
2013/5/9
WASHINGTON , May 9, 2013 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) , a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced financial and operational results for the first quarter ended March 31, 2013 .
Sign-up for Vanda Pharmaceuticals Reports First Quarter 2013 Results investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Valmont Industries, Inc. Fourth Quarter 2012 Earnings Conference Call to Vanda Pharmaceuticals Reports First Quarter 2013 Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity